Search

Your search keyword '"Neuzillet, Cindy"' showing total 567 results
Start Over Author "Neuzillet, Cindy"
567 results on '"Neuzillet, Cindy"'

2. Tumor mutational burden assessment and standardized bioinformatics approach using custom NGS panels in clinical routine

Author

Dupain, Célia, Gutman, Tom, Girard, Elodie, Kamoun, Choumouss, Marret, Grégoire, Castel-Ajgal, Zahra, Sablin, Marie-Paule, Neuzillet, Cindy, Borcoman, Edith, Hescot, Ségolène, Callens, Céline, Trabelsi-Grati, Olfa, Melaabi, Samia, Vibert, Roseline, Antonio, Samantha, Franck, Coralie, Galut, Michèle, Guillou, Isabelle, Halladjian, Maral, Allory, Yves, Cyrta, Joanna, Romejon, Julien, Frouin, Eleonore, Stoppa-Lyonnet, Dominique, Wong, Jennifer, Le Tourneau, Christophe, Bièche, Ivan, Servant, Nicolas, Kamal, Maud, and Masliah-Planchon, Julien

Published
2024
Full Text
View/download PDF

5. Ampullary tumors: French Intergroup Clinical Practice Guidelines for diagnosis, treatments and follow-up (TNCD, SNFGE, FFCD, UNICANCER, GERCOR, SFCD, SFED, ACHBT, AFC, SFRO, RENAPE, SNFCP, AFEF, SFP, SFR)

Author

Hautefeuille, Vincent, Williet, Nicolas, Turpin, Anthony, Napoleon, Bertrand, Dupré, Aurélien, Huguet, Florence, Bignon, Anne Laure, Camus, Marine, Chevaux, Jean-Baptiste, Coriat, Romain, Cros, Jérôme, Edeline, Julien, Koch, Stéphane, Neuzillet, Cindy, Perkins, Géraldine, Regimbeau, Jean Marc, Sefrioui, David, Vitellius, Carole, Vullierme, Marie-Pierre, Bouché, Olivier, and Gaujoux, Sébastien

Published
2024
Full Text
View/download PDF

6. Pacpaint: a histology-based deep learning model uncovers the extensive intratumor molecular heterogeneity of pancreatic adenocarcinoma

Author

Saillard, Charlie, Delecourt, Flore, Schmauch, Benoit, Moindrot, Olivier, Svrcek, Magali, Bardier-Dupas, Armelle, Emile, Jean Francois, Ayadi, Mira, Rebours, Vinciane, de Mestier, Louis, Hammel, Pascal, Neuzillet, Cindy, Bachet, Jean Baptiste, Iovanna, Juan, Dusetti, Nelson, Blum, Yuna, Richard, Magali, Kermezli, Yasmina, Paradis, Valerie, Zaslavskiy, Mikhail, Courtiol, Pierre, Kamoun, Aurelie, Nicolle, Remy, and Cros, Jerome

Published
2023
Full Text
View/download PDF

7. Biliary tract cancers: French national clinical practice guidelines for diagnosis, treatments and follow-up (TNCD, SNFGE, FFCD, UNICANCER, GERCOR, SFCD, SFED, AFEF, SFRO, SFP, SFR, ACABi, ACHBPT)

Author

Roth, Gael S., Verlingue, Loic, Sarabi, Matthieu, Blanc, Jean-Frédéric, Boleslawski, Emmanuel, Boudjema, Karim, Bretagne-Bignon, Anne-Laure, Camus-Duboc, Marine, Coriat, Romain, Créhange, Gilles, De Baere, Thierry, de la Fouchardière, Christelle, Dromain, Clarisse, Edeline, Julien, Gelli, Maximiliano, Guiu, Boris, Horn, Samy, Laurent-Croise, Valérie, Lepage, Côme, Lièvre, Astrid, Lopez, Anthony, Manfredi, Sylvain, Meilleroux, Julie, Neuzillet, Cindy, Paradis, Valérie, Prat, Frédéric, Ronot, Maxime, Rosmorduc, Olivier, Cunha, Antonio Sa, Soubrane, Olivier, Turpin, Anthony, Louvet, Christophe, Bouché, Olivier, and Malka, David

Published
2024
Full Text
View/download PDF

8. Pemigatinib for patients with previously treated, locally advanced or metastatic cholangiocarcinoma harboring FGFR2 fusions or rearrangements: A joint analysis of the French PEMI-BIL and Italian PEMI-REAL cohort studies

Author

Parisi, Alessandro, Delaunay, Blandine, Pinterpe, Giada, Hollebecque, Antoine, Blanc, Jean Frederic, Bouattour, Mohamed, Assenat, Eric, Ben Abdelghani, Meher, Sarabi, Matthieu, Niger, Monica, Vivaldi, Caterina, Mandalà, Mario, Palloni, Andrea, Bensi, Maria, Garattini, Silvio Ken, Tougeron, David, Combe, Pierre, Salati, Massimiliano, Rimini, Margherita, Cella, Chiara Alessandra, Tucci, Marco, Diana, Anna, Mori, Elena, Longarini, Raffaella, Artru, Pascal, Roth, Gael, Evesque, Ludovic, Vienne, Agathe, Turpin, Anthony, Hiret, Sandrine, Bourgeois, Vincent, Herve, Camille, Paulon, Rodolphe, Stacoffe, Marion, Malka, David, Neuzillet, Cindy, Edeline, Julien, Lievre, Astrid, Guimbaud, Rosine, Chapda, Marie Christelle Pajiep, Rimassa, Lorenza, Giampieri, Riccardo, Valle, Juan, Berardi, Rossana, and Fares, Nadim

Published
2024
Full Text
View/download PDF

9. Defining a Space for NRG1 Fusion--Positive Tumors in Lung and GI Cancers

Author

Spira, Alexander I., Macarulla, Teresa, Neuzillet, Cindy, Sabari, Joshua K., Schram, Alison, and Cutsem, Eric Van

Subjects
Tumors -- Care and treatment, RNA, Crizotinib, Health, Memorial Sloan-Kettering Cancer Center
Abstract

Agroup of lung and gastrointestinal (GI) cancer experts gathered during a Frontline Forum event to discuss treatment options for NRG1 fusion--positive tumors. The panel covered how to best detect this [...]

Published
2024

11. Transposition dans les unités de soin des recommandations de bonne pratique de la Haute Autorité de santé sur le diagnostic de la dénutrition de l’enfant, de l’adulte et de la personne âgée

Author

Valla, Frédéric V., Ulmann, Guillaume, Achamrah, Najate, Bedock, Dorothée, Douard, Véronique, Eyraud, Evelyne, Flori, Nicolas, Fraipont, Vincent, Guerriero, Emilie I., Jirka, Adam, Le Gall, Maude, Le Garf, Sébastien, Lecoq, Emilie, Martineau, Caroline, Neuzillet, Cindy, Pierson, Aurore, Poinsot, Pierre, Poullenot, Florian, Quessada, Thierry, Rives-Lange, Claire, Sanchez, Manuel, Van Der Linden, Thierry, Jésus, Pierre, and Guillet, Christelle

Published
2023
Full Text
View/download PDF

15. FAK activity in cancer-associated fibroblasts is a prognostic marker and a druggable key metastatic player in pancreatic cancer.

Author

Zaghdoudi, Sonia, Decaup, Emilie, Belhabib, Ismahane, Samain, Rémi, Cassant-Sourdy, Stéphanie, Rochotte, Julia, Brunel, Alexia, Cros, Jérome, Neuzillet, Cindy, Strehaiano, Manon, Alard, Amandine, Tomasini, Richard, Rajeeve, Vinothini, Perraud, Aurélie, Mathonnet, Muriel, Pearce, Oliver, Martineau, Yvan, Pyronnet, Stéphane, Bousquet, Corinne, Jean, Christine, and Schlaepfer, David

Subjects
cancer-associated fibroblasts, extracellular matrix remodelling, focal adhesion kinase, metastasis, pancreatic ductal adenocarcinoma, Cancer-Associated Fibroblasts, Carcinoma, Pancreatic Ductal, Cell Line, Tumor, Fibroblasts, Humans, Pancreatic Neoplasms, Phosphorylation, Prognosis
Abstract

Cancer-associated fibroblasts (CAFs) are considered the most abundant type of stromal cells in pancreatic ductal adenocarcinoma (PDAC), playing a critical role in tumour progression and chemoresistance; however, a druggable target on CAFs has not yet been identified. Here we report that focal adhesion kinase (FAK) activity (evaluated based on 397 tyrosine phosphorylation level) in CAFs is highly increased compared to its activity in fibroblasts from healthy pancreas. Fibroblastic FAK activity is an independent prognostic marker for disease-free and overall survival of PDAC patients (cohort of 120 PDAC samples). Genetic inactivation of FAK within fibroblasts (FAK kinase-dead, KD) reduces fibrosis and immunosuppressive cell number within primary tumours and dramatically decreases tumour spread. FAK pharmacologic or genetic inactivation reduces fibroblast migration/invasion, decreases extracellular matrix (ECM) expression and deposition by CAFs, modifies ECM track generation and negatively impacts M2 macrophage polarization and migration. Thus, FAK activity within CAFs appears as an independent PDAC prognostic marker and a druggable driver of tumour cell invasion.

Published
2020

17. Intratumoral microbiome is driven by metastatic site and associated with immune histopathological parameters: An ancillary study of the SHIVA clinical trial

Author

Hilmi, Marc, Kamal, Maud, Vacher, Sophie, Dupain, Célia, Ibadioune, Sabrina, Halladjian, Maral, Sablin, Marie Paule, Marret, Grégoire, Ajgal, Zahra Castel, Nijnikoff, Michèle, Salomon, Anne, El Beaino, Zakhia, Servant, Nicolas, Dureau, Sylvain, Sokol, Harry, Nicolle, Remy, Le Tourneau, Christophe, Bieche, Ivan, and Neuzillet, Cindy

Published
2023
Full Text
View/download PDF

20. Management of intrahepatic and perihilar cholangiocarcinomas: Guidelines of the French Association for the Study of the Liver (AFEF).

Author

Neuzillet, Cindy, Decraecker, Marie, Larrue, Hélène, Ntanda‐Nwandji, Line C., Barbier, Louise, Barge, Sandrine, Belle, Arthur, Chagneau, Carine, Edeline, Julien, Guettier, Catherine, Huguet, Florence, Jacques, Jérémie, Le Bail, Brigitte, Leblanc, Sarah, Lewin, Maïté, Malka, David, Ronot, Maxime, Vendrely, Véronique, Vibert, Éric, and Bureau, Christophe

Subjects
*BILIOUS diseases & biliousness, *DISEASE incidence, *LIVER diseases, *LIVER cancer, *INDIVIDUALIZED medicine
Abstract

Intrahepatic cholangiocarcinoma (iCCA) is the second most common malignant primary liver cancer. iCCA may develop on an underlying chronic liver disease and its incidence is growing in relation with the epidemics of obesity and metabolic diseases. In contrast, perihilar cholangiocarcinoma (pCCA) may follow a history of chronic inflammatory diseases of the biliary tract. The initial management of CCAs is often complex and requires multidisciplinary expertise. The French Association for the Study of the Liver wished to organize guidelines in order to summarize the best evidence available about several key points in iCCA and pCCA. These guidelines have been elaborated based on the level of evidence available in the literature and each recommendation has been analysed, discussed and voted by the panel of experts. They describe the epidemiology of CCA as well as how patients with iCCA or pCCA should be managed from diagnosis to treatment. The most recent developments of personalized medicine and use of targeted therapies are also highlighted. [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

21. Activité physique et prise en charge nutritionnelle dans les cancers du pancréas : un traitement à part entière !

Author

Beltran, Eva Ester Molina, Trihan, Clémence, and Neuzillet, Cindy

Subjects
PANCREATIC cancer, FATIGUE (Physiology), FUNCTIONAL status, PHYSICAL activity, OVERALL survival
Abstract

Copyright of Hépato-Gastro & Oncologie Digestive is the property of John Libbey Eurotext Ltd. and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)

Published
2024
Full Text
View/download PDF

27. Pharmacologic Normalization of Pancreatic Cancer-Associated Fibroblast Secretome Impairs Prometastatic Cross-Talk With Macrophages

Author

Samain, Rémi, Brunel, Alexia, Douché, Thibault, Fanjul, Marjorie, Cassant-Sourdy, Stéphanie, Rochotte, Julia, Cros, Jérôme, Neuzillet, Cindy, Raffenne, Jérôme, Duluc, Camille, Perraud, Aurélie, Nigri, Jérémy, Gigoux, Véronique, Bieche, Ivan, Ponzo, Matteo, Carpentier, Gilles, Cascone, Ilaria, Tomasini, Richard, Schmid, Herbert A., Mathonnet, Muriel, Nicolle, Rémy, Bousquet, Marie-Pierre, Martineau, Yvan, Pyronnet, Stéphane, Jean, Christine, and Bousquet, Corinne

Published
2021
Full Text
View/download PDF

28. Management of biliary tract cancers in early‐onset patients: A nested multicenter retrospective study of the ACABI GERCOR PRONOBIL cohort.

Author

Lebeaud, Antoine, Antoun, Leony, Paccard, Jane‐Rose, Edeline, Julien, Bourien, Hélène, Fares, Nadim, Tournigand, Christophe, Lecomte, Thierry, Tougeron, David, Hautefeuille, Vincent, Viénot, Angélique, Henriques, Julie, Williet, Nicolas, Bachet, Jean‐Baptiste, Smolenschi, Cristina, Hollebecque, Antoine, Macarulla, Teresa, Castet, Florian, Malka, David, and Neuzillet, Cindy

Subjects
BILIARY tract cancer, CANCER patients, PROGRESSION-free survival, GALLBLADDER cancer, GASTROINTESTINAL cancer, OVERALL survival
Abstract

Background & Aims: Accumulating data has shown the rising incidence and poor prognosis of early‐onset gastrointestinal cancers, but few data exist on biliary tract cancers (BTC). We aimed to analyse the clinico‐pathological, molecular, therapeutic characteristics and prognosis of patients with early onset BTC (EOBTC, age ≤50 years at diagnosis), versus olders. Methods: We analysed patients diagnosed with intrahepatic cholangiocarcinoma, extrahepatic cholangiocarcinoma, and gallbladder adenocarcinoma between 1 January 2003 and 30 June 2021. Baseline characteristics and treatment were described in each group and compared. Progression‐free survival, overall survival and disease‐free survival were estimated in each group using the Kaplan‐Meier method. Results: Overall, 1256 patients were included, 188 (15%) with EOBTC. Patients with EOBTC demonstrated fewer comorbidities (63.5% vs. 84.5%, p <.0001), higher tumour stage (cT3–4: 50.0% vs. 32.3%, p =.0162), bilobar liver involvement (47.8% vs. 32.1%, p =.0002), and metastatic disease (67.6% vs. 57.5%, p =.0097) compared to older. Patients with EOBTC received second‐line therapy more frequently (89.5% vs. 81.0% non‐EOBTC, p =.0224). For unresectable patients with BTC, median overall survival was 17.0 vs. 16.2 months (p =.0876), and median progression‐free survival was 5.8 vs. 6.0 months (p =.8293), in EOBTC vs. older. In advanced stages, fewer actionable alterations were found in EOBTC (e.g., IDH1 mutations [7.8% vs. 16.6%]; FGFR2‐fusion [11.7% vs. 8.9%]; p =.029). Conclusions: Patients with EOBTC have a more advanced disease at diagnosis, are treated more heavily at an advanced stage but show similar survival. A distinctive molecular profile enriched for FGRF2 fusions was found. [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

29. L'activité physique adaptée et le parcours de soins des patients en oncologie.

Author

Beltran, Eva Ester Molina, Neuzillet, Cindy, and Chorin, Frédéric

Abstract

The maintenance and optimization of functional capacities before, during, and after treatments are major challenges for individuals with cancer. It is now well established that physical activity in prehabilitation before surgery plays a crucial role in limiting, among other things, post-operative complications. The benefits have already been demonstrated in various studies, including a decrease in hospitalization length of stay, an increase in cardiorespiratory endurance, improvement in quality of life, and better fatigue management. It is observed that patients who undergo prehabilitation are those who recover their functional capacities the fastest. However, it is estimated that only one-third of patients with access to prehabilitation improve their physical capacities. The modalities of intervention and follow-up (adherence, generic format, etc.) seem to be a barrier to patient engagement in these programs and may explain this low result, despite the well-established benefits of adapted physical activity. In this context, this article aims to present the interest of Adapted Physical Activity (APA) in the patient care journey. The awareness about APA during the cancer treatment phase is increasing and highlights the integration of this approach into supportive care in oncology, just like nutrition. [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

31. The phase I/II eNRGy trial: Zenocutuzumab in patients with cancers harboring NRG1 gene fusions

Author

Kim, Dong-Wan, primary, Schram, Alison M, additional, Hollebecque, Antoine, additional, Nishino, Kazumi, additional, Macarulla, Teresa, additional, Rha, Sun Young, additional, Duruisseaux, Michaël, additional, Liu, Stephen V, additional, Al Hallak, Mohammed Najeeb, additional, Umemoto, Kumiko, additional, Wesseler, Claas, additional, Cleary, James M, additional, Springfeld, Christoph, additional, Neuzillet, Cindy, additional, Joe, Andrew, additional, Jauhari, Shekeab, additional, Ford, Jim, additional, and Goto, Koichi, additional

Published
2024
Full Text
View/download PDF

32. Maintenance therapy with olaparib or selumetinib plus durvalumab (S+D) according to genetic profile of metastatic pancreatic adenocarcinoma (m-PDAC) controlled with modified FOLFIRINOX (mFFX): A phase II randomized MAZEPPA GERCOR D19-02 PRODIGE-72 study.

Author

Hammel, Pascal, primary, Ben Abdelghani, Meher, additional, Roth, Gael, additional, Ulusakarya, Ayhan, additional, Ghiringhelli, François, additional, Toullec, Clemence, additional, Borg, Christophe, additional, Hentic Dhome, Olivia, additional, Trouilloud, Isabelle, additional, Dahan, Laetitia, additional, Hiret, Sandrine, additional, Bouche, Olivier, additional, Rinaldi, Yves, additional, Blanc, Jean-Frédéric, additional, De La Fouchardiere, Christelle, additional, Neuzillet, Cindy, additional, Kamal, Maud, additional, Falcoz, Antoine, additional, Turpin, Anthony, additional, and Guimbaud, Rosine, additional

Published
2024
Full Text
View/download PDF

33. Gemcitabine and Paclitaxel Versus Gemcitabine Alone After 5-Fluorouracil, Oxaliplatin, and Irinotecan in Metastatic Pancreatic Adenocarcinoma: A Randomized Phase III PRODIGE 65-UCGI 36-GEMPAX UNICANCER Study

Author

De La Fouchardière, Christelle, primary, Malka, David, additional, Cropet, Claire, additional, Chabaud, Sylvie, additional, Raimbourg, Judith, additional, Botsen, Damien, additional, Launay, Simon, additional, Evesque, Ludovic, additional, Vienot, Angélique, additional, Perrier, Hervé, additional, Jary, Marine, additional, Rinaldi, Yves, additional, Coutzac, Clélia, additional, Bachet, Jean Baptiste, additional, Neuzillet, Cindy, additional, Williet, Nicolas, additional, Desgrippes, Romain, additional, Grainville, Thomas, additional, Aparicio, Thomas, additional, Peytier, Annie, additional, Lecomte, Thierry, additional, Roth, Gaël S., additional, Thirot-Bidault, Anne, additional, Lachaux, Nicolas, additional, Bouché, Olivier, additional, and Ghiringhelli, François, additional

Published
2024
Full Text
View/download PDF

34. Abstract B064: Redefining phenotypic heterogeneity of pancreatic ductal adenocarcinoma: A bottom-up approach

Author

Hilmi, Marc, primary, Delecourt, Flore, additional, Rafenne, Jerôme, additional, Bourega, Taib, additional, Dusetti, Nelson, additional, Iovanna, Juan, additional, Blum, Yuna, additional, Richard, Magali, additional, Neuzillet, Cindy, additional, Couvelard, Anne, additional, De Mestier, Louis, additional, Rebours, Vinciane, additional, Nicolle, Rémy, additional, and Cros, Jérôme, additional

Published
2024
Full Text
View/download PDF

36. Effect of Adapted Physical Activity in Patients With Advanced Pancreatic Cancer: The APACaP GERCOR Randomized Trial

Author

Neuzillet, Cindy, primary, Bouché, Olivier, additional, Tournigand, Christophe, additional, Chibaudel, Benoist, additional, Bauguion, Lucile, additional, Bengrine-Lefevre, Leïla, additional, Lopez-Trabada Ataz, Daniel, additional, Mabro, May, additional, Metges, Jean-Philippe, additional, Péré-Vergé, Denis, additional, Conroy, Thierry, additional, Lièvre, Astrid, additional, Andre, Morgan, additional, Desseigne, Françoise, additional, Goldwasser, François, additional, Henriques, Julie, additional, Anota, Amélie, additional, and Hammel, Pascal, additional

Published
2023
Full Text
View/download PDF

37. Prognostic value of intratumoral Fusobacterium nucleatum and association with immune-related gene expression in oral squamous cell carcinoma patients

Author

Neuzillet, Cindy, Marchais, Manon, Vacher, Sophie, Hilmi, Marc, Schnitzler, Anne, Meseure, Didier, Leclere, Renaud, Lecerf, Charlotte, Dubot, Coraline, Jeannot, Emmanuelle, Klijanienko, Jerzy, Mariani, Odette, Calugaru, Valentin, Hoffmann, Caroline, Lesnik, Maria, Badois, Nathalie, Borcoman, Edith, Piaggio, Eliane, Kamal, Maud, Le Tourneau, Christophe, and Bieche, Ivan

Published
2021
Full Text
View/download PDF

41. Pancreatic cancer: French clinical practice guidelines for diagnosis, treatment and follow-up (SNFGE, FFCD, GERCOR, UNICANCER, SFCD, SFED, SFRO, ACHBT, AFC)

Author

Neuzillet, Cindy, Gaujoux, Sébastien, Williet, Nicolas, Bachet, Jean-Baptiste, Bauguion, Lucile, Colson Durand, Laurianne, Conroy, Thierry, Dahan, Laetitia, Gilabert, Marine, Huguet, Florence, Marthey, Lysiane, Meilleroux, Julie, de Mestier, Louis, Napoléon, Bertrand, Portales, Fabienne, Sa Cunha, Antonio, Schwarz, Lilian, Taieb, Julien, Chibaudel, Benoist, Bouché, Olivier, and Hammel, Pascal

Published
2018
Full Text
View/download PDF

42. Redefining phenotypic intratumor heterogeneity of pancreatic ductal adenocarcinoma: a bottom-up approach

Author

Hilmi, Marc, primary, Delecourt, Flore, additional, Raffenne, Jérôme, additional, Bourega, Taib, additional, Dusetti, Nelson, additional, Iovanna, Juan, additional, Blum, Yuna, additional, Richard, Magali, additional, Neuzillet, Cindy, additional, Couvelard, Anne, additional, de Mestier, Louis, additional, Rebours, Vinciane, additional, Nicolle, Rémy, additional, and Cros, Jérôme, additional

Published
2023
Full Text
View/download PDF

43. Pathogenic alterations in PIK3CA and KMT2C are frequent and independent prognostic factors in anal squamous cell carcinoma treated with salvage abdominoperineal resection

Author

Hamza, Abderaouf, primary, Masliah‐Planchon, Julien, additional, Neuzillet, Cindy, additional, Lefèvre, Jérémie H., additional, Svrcek, Magali, additional, Vacher, Sophie, additional, Bourneix, Christine, additional, Delaye, Matthieu, additional, Goéré, Diane, additional, Dartigues, Peggy, additional, Samalin, Emmanuelle, additional, Hilmi, Marc, additional, Lazartigues, Julien, additional, Girard, Elodie, additional, Emile, Jean‐François, additional, Rigault, Eugénie, additional, Dangles‐Marie, Virginie, additional, Rioux‐Leclercq, Nathalie, additional, de la Fouchardière, Christelle, additional, Tougeron, David, additional, Casadei‐Gardini, Andrea, additional, Mariani, Pascale, additional, Peschaud, Frédérique, additional, Cacheux, Wulfran, additional, Lièvre, Astrid, additional, and Bièche, Ivan, additional

Published
2023
Full Text
View/download PDF

50. Correction: Schwann cells support oncogenic potential of pancreatic cancer cells through TGFβ signaling

Author

Roger, Elodie, Martel, Sylvie, Bertrand-Chapel, Adrien, Depollier, Arnaud, Chuvin, Nicolas, Pommier, Roxane M., Yacoub, Karam, Caligaris, Cassandre, Cardot-Ruffino, Victoire, Chauvet, Véronique, Aires, Sophie, Mohkam, Kayvan, Mabrut, Jean-Yves, Adham, Mustapha, Fenouil, Tanguy, Hervieu, Valérie, Broutier, Laura, Castets, Marie, Neuzillet, Cindy, Cassier, Philippe A., Tomasini, Richard, Sentis, Stéphanie, and Bartholin, Laurent

Published
2020
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results